Micron, Novavax, Bed Bath & Beyond, and More Stock Market Movers

Bed Bath & Beyond climbs higher in the premarket Tuesday.

Michael M. Santiago/Getty Images

Stock futures were trading lower on Tuesday, ahead of the Wednesday release of the inflation data, which will give Wall Street an idea of how aggressive the Federal Reserve will need to be with future interest rate hikes.

S&P 500

 futures were 0.2% lower while 

Dow Jones Industrial Average

 futures were down less than 0.1%. Futures for the tech-heavy 

Nasdaq Composite

 were 0.6% lower.

These are some of the stocks making notable moves in the premarket Tuesday.

Bed Bath & Beyond

(BBBY) jumped 8.8% Tuesday as the meme-stock frenzy continued. Shares for the retailer soared 40% by the close on Monday as the stock once again became a favorite of investors on the Reddit platform.

Covid-19 vaccine developer


(NVAX) sank 32% after the company cut its guidance for 2022 revenue.

Micron Technology

(MU) was 3.5% lower Tuesday. The memory chip company said it was reducing its guidance for fourth-quarter revenue. The company also said that it plans to invest $40 billion in the U.S. through the end of the decade.

Upstart Holdings

(UPST) reported earnings and revenue that missed Wall Street consensus for its second quarter after the close on Monday. Shares for the consumer-lending company fell 13% in the premarket on Tuesday.

Take-Two Interactive Software

(TTWO) was down 3.4% after the videogame firm reported an earnings and net bookings miss for its fiscal first quarter on Monday.

Palantir Technologies

(PLTR) was 1.7% lower Tuesday after getting a stock downgrade to Sell from Hold at

Deutsche Bank

Shares closed 14% in the red Monday after the data analytics software company provided guidance for both the September quarter and the full year that was below analysts’ estimates.

Spirit Airlines

(SAVE) reported a narrower loss and better revenue for its second-quarter than Wall Street expected on Tuesday. Shares for the discount airline were 0.1% higher.

Write to Angela Palumbo at angela.palumbo@dowjones.com

Leave a Reply

Your email address will not be published. Required fields are marked *